Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study. (April 2019) - Gomoll, A.; Spitzer, A.; Richmond, J.C.; Kraus, V.B.; Jones, D.G.; Huffman, K.M.; Cinar, A.; Lufkin, J.; Kelley, S.